Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07728695) titled 'Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain' on July 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Staci Gruber, Ph.D.

Condition: Endometriosis Adenomyosis Chronic Pelvic Inflammatory Disease

Intervention: Drug: Custom-formulated, high-CBD study product

Recruitment Status: Recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: September 2026

Target Sample Size: 60

Cou...